Cervical insufficiency is a condition in which the cervix is weak and unable to hold a pregnancy, leading to premature delivery or miscarriage
PATHOGENESIS:
Structural abnormalities in the cervix, such as a short or weak cervix, cervical incompetence or previous cervical surgery
Hormonal changes that affect cervical function, such as progesterone deficiency or imbalance
Infection or inflammation of the cervix or uterus, such as bacterial vaginosis, cervicitis or chorioamnionitis
Genetic factors, including inherited connective tissue disorders that affect the strength and structure of the cervix
Environmental factors, such as exposure to toxins or radiation that can damage cervical tissue
Behavioral factors, such as smoking or substance abuse, which can increase the risk of cervical insufficiency.
PATHOGENESIS
Structural abnormalities
Hormonal changes
Infection or inflammation of the cervix or uterus
Genetic factors
Environmental factors
Behavioral factors
PREVALENCE
Account for approximately 10-15% of preterm births
The prevalence of cervical insufficiency in preterm labor ranged from 2.2% to 20.5%, with an overall prevalence of 7.1%
Common in women with a history of preterm birth or cervical surgery
The prevalence rates can vary depending on the population being studied and the diagnostic criteria used
INTERVENTIONS
Cervical cerclage
Progesterone supplementation
Bed rest and pelvic rest
Treatment of infections or inflammation
Tocolytic medications to suppress contractions
Rescue cerclage in cases of failed cerclage or advanced cervical dilation
Cervical pessary to support the cervix
Amniocentesis to assess fetal lung maturity in case of imminent preterm birth
Expectant management with close monitoring and follow-up
INEFFICIENT INTERVENTIONS
Delayed diagnosis and management
Inappropriate use of tocolytic medications without addressing the underlying cause
Inadequate or inappropriate cervical cerclage placement or technique
Inconsistent or inadequate use of progesterone supplementation
Failure to address co-existing conditions such as infection, inflammation, or uterine overdistension
Insufficient or inadequate monitoring and follow-up of patients with cervical insufficiency
Untimely and inappropriate use of rescue cerclage or other interventions
Failure to consider individual patient factors such as gestational age, cervical length, and obstetrical history when selecting interventions.
FUTURE INTERVENTIONS
Improved diagnostic tools: biomarkers, imaging
Advancements in cerclage techniques: minimally invasive, biodegradable materials
Personalized treatment approaches based on patient factors
Investigate new pharmacological therapies: collagen synthesis, anti-inflammatories
Non-surgical interventions: cervical pessaries, support devices
Telemedicine and remote monitoring integration
Large-scale clinical trials and registries
RESEARCH GAPS
Reliable biomarkers and imaging
Efficacy and safety of cerclage
Role of non-surgical interventions
Personalized treatment algorithms
Patient education and support
Long-term outcomes and quality of life
Underlying pathophysiology exploration
Green, E. S., & Arck, P. C. (2020, August). Pathogenesis of preterm birth: bidirectional inflammation in mother and fetus. In Seminars in Immunopathology (Vol. 42, No. 4, pp. 413-429). Berlin/Heidelberg: Springer Berlin Heidelberg.
Robinson, J. N., & Norwitz, E. R. (2018). Preterm birth: Risk factors, interventions for risk reduction, and maternal prognosis. UpToDate.[(accessed on 20 January 2022)]. Available online: https://www. uptodate. com/contents/preterm-birth-risk-factors-interventions-for-risk-reduction-and-maternal-prognosis.
Thakur, M., & Mahajan, K. (2021). Cervical incompetence. In StatPearls [Internet]. StatPearls Publishing.
Inherited pathogenic variants
genetic mutations that increase the risk of preterm labor in a heritable manner
• Polymorphisms: associated with gestational duration/sPTB
• Maternal variants at EBF1, EEFSEC, AGTR2, WNT4, ADCY5, and RAP2C loci associated with gestational duration and at EBF1, EEFSEC, and AGTR2 loci with PTB.
• PTB susceptibility genes identified, but epigenetic and gene-environmental factors play a bigger role than maternal genotype.
RACIAL DISPARITIES
• African American pregnant people have a 50% higher rate of sPTB than non-Hispanic White pregnant people
• Multiple maternal and fetal inflammatory pathway genetic polymorphisms linked to inflammation-associated sPTB are found in greater prevalence among African American mothers and/or fetuses than among other racial groups
• African American mothers harboring both a polymorphism of the tumor necrosis factor-alpha gene and bacterial vaginosis are at significantly greater risk of PTB (odds ratio 6.1, 95% CI 1.9-21.0)
• Higher vaginal levels of the host-derived antimicrobial peptide, beta-defensin 2, are linked to a lowered risk of sPTB
• Lower levels of beta-defensin 2 were linked to spontaneous PTB only among African American pregnant people.
INTERVENTIONS
• Genetic counseling and testing
• Prenatal screening and diagnosis
• Preimplantation genetic diagnosis
• In vitro fertilization with donor eggs or sperm
• Use of assisted reproductive technologies
• Prophylactic measures during pregnancy, such as cervical cerclage or progesterone supplementation.
FUTURE INTERVENTIONS
• Comprehensive genetic testing panels
• Gene therapies for genetic variants
• Personalized medicine approaches
• Understanding genetic-environment interactions
• Medications targeting genetic pathways
• CRISPR-Cas9 for genetic modification
• Non-invasive diagnostic tools development
RESEARCH GAPS
Want to print your doc? This is not the way.
Try clicking the ⋯ next to your doc name or using a keyboard shortcut (